Efficacy and safety of inclisiran in patients with cerebrovascular disease: ORION-9, ORION-10, and ORION-11

• Autores principales: Wolfgang Koenig (Autor), Kausik K. Ray (Autor), Ulf Landmesser (Autor), Lawrence A. Leiter (Autor), Gregory G. Schwartz (Autor), R. Scott Wright (Autor), Lorena Garcia Conde (Autor), Jackie Han (Autor), Frederick J. Raal (Autor)
• Formato: Libro
• Publicado: Elsevier, 2023-06-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Patients with cerebrovascular disease (CeVD) have been shown to benefit from lipid-lowering therapies, but guideline-recommended levels of low-density lipoprotein cholesterol (LDL-C) are often not attained with statin treatment alone. The ORION-9, ORION-10, and ORION-11 trials evaluated the efficacy...